ASP Forms Strategic Alliance With ChemDAQ to Enhance Safety and Compliance in Sterile Processing

Key Takeaways

Advanced Sterilization Products partners with ChemDAQ to enhance safety in healthcare sterilization environments.
The collaboration focuses on meeting evolving standards, including AAMI ST58, for sterilant exposure and workplace safety.
Both companies aim to improve visibility and compliance in sterile processing through their combined expertise.

Partnership Announcement

Advanced Sterilization Products (ASP), a leader in infection prevention and low-temperature sterilization, has announced a strategic partnership with ChemDAQ, a provider of hazardous gas detection solutions. This collaboration aims to support healthcare organizations by enhancing safety practices, ensuring regulatory compliance, and promoting best-in-class sterile processing environments.

The partnership is built on industry engagement and thought leadership, focusing on how to help sterile processing professionals adhere to evolving standards and guidelines, including AAMI ST58. These efforts exemplify ASP’s dedication to continuous improvement and practical innovation tailored to true workplace needs.

Combining ASP’s low-temperature sterilization technology with ChemDAQ’s continuous monitoring expertise, the partnership seeks to provide healthcare teams with the tools necessary to manage risks effectively. By improving visibility and maintaining high-performance standards across reprocessing workflows, the collaboration aims to significantly bolster safety in sterile processing departments (SPDs).

Chad Rohrer, Group President of Fortive Infection Prevention Group, emphasized ASP’s commitment to safeguarding both patients and healthcare professionals. The partnership with ChemDAQ not only delivers advanced technology but also fosters a sense of confidence through education, evidence-based practices, and solutions designed for compliant sterile processing.

ASP’s sterilization systems are integrated into medical facilities worldwide, aiding in the effective reprocessing of complex medical devices. By utilizing ChemDAQ’s monitoring capabilities for sterilant gases such as hydrogen peroxide, the partnership enhances safety awareness in SPDs, supporting compliance and worker safety.

Alex Hilliker, Executive Vice President of ChemDAQ, echoed the commitment to safety, reliability, and accountability in sterile processing, stating that this partnership will assist healthcare facilities in navigating complexities while protecting both patients and staff.

This collaboration marks an important step in aligning the strengths of both companies, aiming to improve the overall safety and efficiency of sterile processing environments in healthcare institutions.

The content above is a summary. For more details, see the source article.